As explained in the article, "The U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences on Wednesday (May 26, 2010) awarded Abbott the benefit of its earliest-filed application and entered judgment against Yeda, which had long contended that it made reference to the binding protein prior to Abbott's patent application, rendering Abbott’s patent claims invalid. … The board declared that Abbott's May 9, 1989, filing of an application for a German patent covering the protein, which is protected by U.S. Patent Number 5,344,915, beat out Yeda's May 18, 1989, filing date, which had initially been granted priority."
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.